Brief: Theranexus H1 Net Loss Widens To Eur 2.8 Million
Sept 27 (Reuters) - Theranexus SA ALTHX.PA :
* ANNOUNCED ON THURSDAY H1 OPERATING LOSS EUR 3.6 MILLION
VERSUS
LOSS OF EUR 2.9 MILLION YEAR AGO
* H1 NET LOSS EUR 2.8 MILLION VERSUS LOSS OF EUR 2.1 MILLION
YEAR
AGO
* H1 NO REVENUE VERSUS NO REVENUE YEAR AGO
Source text for Eikon: urn:newsml:reuters.com:*:nACT60305
Further company coverage: ALTHX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 7720920;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease